An Altogether Different Kind Of CDMO: Freiburg Oral Solids

Patients are at the heart of everything we do. With every tablet and capsule we manufacture, we help deliver life-changing breakthroughs. Our vision is to bring medicines to patients with speed, efficiency, and cost-effectiveness through intelligent collaboration. In 2023, we produced approximately 6.7 million tablets and capsules, with the capacity to support millions of patients worldwide.

Our expertise spans a broad range of therapeutic areas, including oncology, cardiovascular diseases, neurological disorders, rheumatology, and pain management, reinforcing our commitment to advancing global health.